NCT04708418 2026-05-14A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting60 enrolled